These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 32799111)
21. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma. Wu L; Liu G; He YW; Chen R; Wu ZY Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952 [TBL] [Abstract][Full Text] [Related]
22. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
23. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma. Wu X; Chen S; Ji Q; Chen H; Chen X Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879 [TBL] [Abstract][Full Text] [Related]
24. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
25. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma. Qu Y; Zhang S; Zhang Y; Feng X; Wang F Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141 [TBL] [Abstract][Full Text] [Related]
26. Prognostic and immune infiltration implications of SIGLEC9 in SKCM. Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970 [TBL] [Abstract][Full Text] [Related]
27. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma. Lin W; Tan ZY; Fang XC SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541 [TBL] [Abstract][Full Text] [Related]
28. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model. Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498 [TBL] [Abstract][Full Text] [Related]
29. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma. Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451 [TBL] [Abstract][Full Text] [Related]
30. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients. Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744 [TBL] [Abstract][Full Text] [Related]
31. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398 [TBL] [Abstract][Full Text] [Related]
32. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related]
33. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma. Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879 [TBL] [Abstract][Full Text] [Related]
34. Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma. Han W; Shen GL Int Immunopharmacol; 2020 Nov; 88():106958. PubMed ID: 33182068 [TBL] [Abstract][Full Text] [Related]
35. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis. Ren TY; Zhang YX; Hu W Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656 [TBL] [Abstract][Full Text] [Related]
36. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment. Liang Z; Pan L; Shi J; Zhang L Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341 [TBL] [Abstract][Full Text] [Related]
37. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. Long S; Xu J; Huang H Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280 [TBL] [Abstract][Full Text] [Related]
38. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045 [TBL] [Abstract][Full Text] [Related]
39. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma. Cen X; Li M; Yao A; Zheng Y; Lai W J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069 [TBL] [Abstract][Full Text] [Related]
40. Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients. Si Z; Hu H Med Sci Monit; 2021 Jul; 27():e932052. PubMed ID: 34247183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]